<?xml version="1.0"?>
<rss version="2.0">
 <channel>
  <title>StreetInsider.com News Articles</title>
  <link>http://new.streetinsider.com</link>
  <description>Latest StreetInsider.com News Articles</description>
  <language>en-us</language>
  <copyright>Copyright 2026, StreetInsider.com</copyright>
  <managingEditor>rss@streetinsider.com (SI RSS)</managingEditor>
  <webMaster>rss@streetinsider.com (SI RSS)</webMaster>
  <lastBuildDate>Tue, 28 Jul 2026 01:03:00 -0400</lastBuildDate>
  <docs>http://blogs.law.harvard.edu/tech/rss</docs>
  <image>
   <url>http://www.streetinsider.com/images/rss_logo.gif</url>
   <title>StreetInsider.com News Articles</title>
   <link>http://new.streetinsider.com</link>
   <width>143</width>
   <height>28</height>
  </image>
  <skipHours>
   <hour>0</hour>
   <hour>1</hour>
   <hour>2</hour>
   <hour>3</hour>
   <hour>21</hour>
   <hour>22</hour>
   <hour>23</hour>
  </skipHours>
  <skipDays>
   <day>Saturday</day>
   <day>Sunday</day>
  </skipDays>
  <item>
   <title>Aroa Biosurgery Limited announces the recent appointments of Michael Lynskey and Mike Falcon to its US-based commercial team.</title>
   <link>http://www.streetinsider.com/Press+Releases/Aroa+Biosurgery+Limited+announces+the+recent+appointments+of+Michael+Lynskey+and+Mike+Falcon+to+its+US-based+commercial+team./26820941.html</link>
   <description>
&lt;div class=&quot;xn-content&quot;&gt;
&lt;p&gt;&lt;span class=&quot;legendSpanClass&quot;&gt;&lt;location value=&quot;LU/nz..auckld&quot; idsrc=&quot;xmltag.org&quot; &gt;AUCKLAND, New Zealand&lt;/location&gt;&lt;/span&gt;, &lt;span class=&quot;legendSpanClass&quot;&gt;&lt;chron&gt;July 28, 2026&lt;/chron&gt;&lt;/span&gt; /PRNewswire/ -- &lt;span id=&quot;spanHghlt0915&quot;&gt;&lt;span value=&quot;Australia:ARX&quot; idsrc=&quot;xmltag.org&quot; &gt;Aroa Biosurgery Limited&lt;/span&gt; announces the recent appointments of &lt;person&gt;Michael Lynskey&lt;/person&gt; and &lt;person&gt;Mike Falcon&lt;/person&gt; to its US-based commercial team.&lt;/span&gt;&lt;/p&gt;
&lt;p&gt;AROA has been investing in expanding its commercial organisation to support its growth strategy and adoption of its AROA ECM™ technology. These appointments add seasoned leadership capability to support continued momentum across the Myriad product portfolio, and to capitalise on the recent market reset that has increased the opportunity for AROA's outpatient product, Symphony.&lt;/p&gt;&lt;p&gt;&lt;person&gt;Michael Lynskey&lt;/person&gt; has been appointed as the Chief Commercial Officer and is</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Aroa+Biosurgery+Limited+announces+the+recent+appointments+of+Michael+Lynskey+and+Mike+Falcon+to+its+US-based+commercial+team./26820941.html</guid>
   <pubDate>Tue, 28 Jul 2026 01:03:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.04540386</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.06505605</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ARX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00070321</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.09488366</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.14540318</category>
   	  </item>
  <item>
   <title>Aroa Biosurgery Limited announces the recent appointments of Michael Lynskey and Mike Falcon to its US-based commercial team.</title>
   <link>http://www.streetinsider.com/Press+Releases/Aroa+Biosurgery+Limited+announces+the+recent+appointments+of+Michael+Lynskey+and+Mike+Falcon+to+its+US-based+commercial+team./26820941.html</link>
   <description>
&lt;div class=&quot;xn-content&quot;&gt;
&lt;p&gt;&lt;span class=&quot;legendSpanClass&quot;&gt;&lt;location value=&quot;LU/nz..auckld&quot; idsrc=&quot;xmltag.org&quot; &gt;AUCKLAND, New Zealand&lt;/location&gt;&lt;/span&gt;, &lt;span class=&quot;legendSpanClass&quot;&gt;&lt;chron&gt;July 28, 2026&lt;/chron&gt;&lt;/span&gt; /PRNewswire/ -- &lt;span id=&quot;spanHghlt0915&quot;&gt;&lt;span value=&quot;Australia:ARX&quot; idsrc=&quot;xmltag.org&quot; &gt;Aroa Biosurgery Limited&lt;/span&gt; announces the recent appointments of &lt;person&gt;Michael Lynskey&lt;/person&gt; and &lt;person&gt;Mike Falcon&lt;/person&gt; to its US-based commercial team.&lt;/span&gt;&lt;/p&gt;
&lt;p&gt;AROA has been investing in expanding its commercial organisation to support its growth strategy and adoption of its AROA ECM™ technology. These appointments add seasoned leadership capability to support continued momentum across the Myriad product portfolio, and to capitalise on the recent market reset that has increased the opportunity for AROA's outpatient product, Symphony.&lt;/p&gt;&lt;p&gt;&lt;person&gt;Michael Lynskey&lt;/person&gt; has been appointed as the Chief Commercial Officer and is</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Aroa+Biosurgery+Limited+announces+the+recent+appointments+of+Michael+Lynskey+and+Mike+Falcon+to+its+US-based+commercial+team./26820941.html</guid>
   <pubDate>Tue, 28 Jul 2026 01:03:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.04540386</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.06505605</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ARX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00070321</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.09488366</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.14540318</category>
   	  </item>
  <item>
   <title>Aroa Biosurgery Limited announces the recent appointments of Michael Lynskey and Mike Falcon to its US-based commercial team.</title>
   <link>http://www.streetinsider.com/Press+Releases/Aroa+Biosurgery+Limited+announces+the+recent+appointments+of+Michael+Lynskey+and+Mike+Falcon+to+its+US-based+commercial+team./26820941.html</link>
   <description>
&lt;div class=&quot;xn-content&quot;&gt;
&lt;p&gt;&lt;span class=&quot;legendSpanClass&quot;&gt;&lt;location value=&quot;LU/nz..auckld&quot; idsrc=&quot;xmltag.org&quot; &gt;AUCKLAND, New Zealand&lt;/location&gt;&lt;/span&gt;, &lt;span class=&quot;legendSpanClass&quot;&gt;&lt;chron&gt;July 28, 2026&lt;/chron&gt;&lt;/span&gt; /PRNewswire/ -- &lt;span id=&quot;spanHghlt0915&quot;&gt;&lt;span value=&quot;Australia:ARX&quot; idsrc=&quot;xmltag.org&quot; &gt;Aroa Biosurgery Limited&lt;/span&gt; announces the recent appointments of &lt;person&gt;Michael Lynskey&lt;/person&gt; and &lt;person&gt;Mike Falcon&lt;/person&gt; to its US-based commercial team.&lt;/span&gt;&lt;/p&gt;
&lt;p&gt;AROA has been investing in expanding its commercial organisation to support its growth strategy and adoption of its AROA ECM™ technology. These appointments add seasoned leadership capability to support continued momentum across the Myriad product portfolio, and to capitalise on the recent market reset that has increased the opportunity for AROA's outpatient product, Symphony.&lt;/p&gt;&lt;p&gt;&lt;person&gt;Michael Lynskey&lt;/person&gt; has been appointed as the Chief Commercial Officer and is</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Aroa+Biosurgery+Limited+announces+the+recent+appointments+of+Michael+Lynskey+and+Mike+Falcon+to+its+US-based+commercial+team./26820941.html</guid>
   <pubDate>Tue, 28 Jul 2026 01:03:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.04540386</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.06505605</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ARX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00070321</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.09488366</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.14540318</category>
   	  </item>
  <item>
   <title>Aroa Biosurgery Limited announces the recent appointments of Michael Lynskey and Mike Falcon to its US-based commercial team.</title>
   <link>http://www.streetinsider.com/Press+Releases/Aroa+Biosurgery+Limited+announces+the+recent+appointments+of+Michael+Lynskey+and+Mike+Falcon+to+its+US-based+commercial+team./26820941.html</link>
   <description>
&lt;div class=&quot;xn-content&quot;&gt;
&lt;p&gt;&lt;span class=&quot;legendSpanClass&quot;&gt;&lt;location value=&quot;LU/nz..auckld&quot; idsrc=&quot;xmltag.org&quot; &gt;AUCKLAND, New Zealand&lt;/location&gt;&lt;/span&gt;, &lt;span class=&quot;legendSpanClass&quot;&gt;&lt;chron&gt;July 28, 2026&lt;/chron&gt;&lt;/span&gt; /PRNewswire/ -- &lt;span id=&quot;spanHghlt0915&quot;&gt;&lt;span value=&quot;Australia:ARX&quot; idsrc=&quot;xmltag.org&quot; &gt;Aroa Biosurgery Limited&lt;/span&gt; announces the recent appointments of &lt;person&gt;Michael Lynskey&lt;/person&gt; and &lt;person&gt;Mike Falcon&lt;/person&gt; to its US-based commercial team.&lt;/span&gt;&lt;/p&gt;
&lt;p&gt;AROA has been investing in expanding its commercial organisation to support its growth strategy and adoption of its AROA ECM™ technology. These appointments add seasoned leadership capability to support continued momentum across the Myriad product portfolio, and to capitalise on the recent market reset that has increased the opportunity for AROA's outpatient product, Symphony.&lt;/p&gt;&lt;p&gt;&lt;person&gt;Michael Lynskey&lt;/person&gt; has been appointed as the Chief Commercial Officer and is</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Aroa+Biosurgery+Limited+announces+the+recent+appointments+of+Michael+Lynskey+and+Mike+Falcon+to+its+US-based+commercial+team./26820941.html</guid>
   <pubDate>Tue, 28 Jul 2026 01:03:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.04540386</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.06505605</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ARX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00070321</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.09488366</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.14540318</category>
   	  </item>
  <item>
   <title>Aroa Biosurgery Limited announces the recent appointments of Michael Lynskey and Mike Falcon to its US-based commercial team.</title>
   <link>http://www.streetinsider.com/Press+Releases/Aroa+Biosurgery+Limited+announces+the+recent+appointments+of+Michael+Lynskey+and+Mike+Falcon+to+its+US-based+commercial+team./26820941.html</link>
   <description>
&lt;div class=&quot;xn-content&quot;&gt;
&lt;p&gt;&lt;span class=&quot;legendSpanClass&quot;&gt;&lt;location value=&quot;LU/nz..auckld&quot; idsrc=&quot;xmltag.org&quot; &gt;AUCKLAND, New Zealand&lt;/location&gt;&lt;/span&gt;, &lt;span class=&quot;legendSpanClass&quot;&gt;&lt;chron&gt;July 28, 2026&lt;/chron&gt;&lt;/span&gt; /PRNewswire/ -- &lt;span id=&quot;spanHghlt0915&quot;&gt;&lt;span value=&quot;Australia:ARX&quot; idsrc=&quot;xmltag.org&quot; &gt;Aroa Biosurgery Limited&lt;/span&gt; announces the recent appointments of &lt;person&gt;Michael Lynskey&lt;/person&gt; and &lt;person&gt;Mike Falcon&lt;/person&gt; to its US-based commercial team.&lt;/span&gt;&lt;/p&gt;
&lt;p&gt;AROA has been investing in expanding its commercial organisation to support its growth strategy and adoption of its AROA ECM™ technology. These appointments add seasoned leadership capability to support continued momentum across the Myriad product portfolio, and to capitalise on the recent market reset that has increased the opportunity for AROA's outpatient product, Symphony.&lt;/p&gt;&lt;p&gt;&lt;person&gt;Michael Lynskey&lt;/person&gt; has been appointed as the Chief Commercial Officer and is</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Aroa+Biosurgery+Limited+announces+the+recent+appointments+of+Michael+Lynskey+and+Mike+Falcon+to+its+US-based+commercial+team./26820941.html</guid>
   <pubDate>Tue, 28 Jul 2026 01:03:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.04540386</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.06505605</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ARX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00070321</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.09488366</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.14540318</category>
   	  </item>
  <item>
   <title>Aroa Biosurgery Limited announces the recent appointments of Michael Lynskey and Mike Falcon to its US-based commercial team.</title>
   <link>http://www.streetinsider.com/Press+Releases/Aroa+Biosurgery+Limited+announces+the+recent+appointments+of+Michael+Lynskey+and+Mike+Falcon+to+its+US-based+commercial+team./26820941.html</link>
   <description>
&lt;div class=&quot;xn-content&quot;&gt;
&lt;p&gt;&lt;span class=&quot;legendSpanClass&quot;&gt;&lt;location value=&quot;LU/nz..auckld&quot; idsrc=&quot;xmltag.org&quot; &gt;AUCKLAND, New Zealand&lt;/location&gt;&lt;/span&gt;, &lt;span class=&quot;legendSpanClass&quot;&gt;&lt;chron&gt;July 28, 2026&lt;/chron&gt;&lt;/span&gt; /PRNewswire/ -- &lt;span id=&quot;spanHghlt0915&quot;&gt;&lt;span value=&quot;Australia:ARX&quot; idsrc=&quot;xmltag.org&quot; &gt;Aroa Biosurgery Limited&lt;/span&gt; announces the recent appointments of &lt;person&gt;Michael Lynskey&lt;/person&gt; and &lt;person&gt;Mike Falcon&lt;/person&gt; to its US-based commercial team.&lt;/span&gt;&lt;/p&gt;
&lt;p&gt;AROA has been investing in expanding its commercial organisation to support its growth strategy and adoption of its AROA ECM™ technology. These appointments add seasoned leadership capability to support continued momentum across the Myriad product portfolio, and to capitalise on the recent market reset that has increased the opportunity for AROA's outpatient product, Symphony.&lt;/p&gt;&lt;p&gt;&lt;person&gt;Michael Lynskey&lt;/person&gt; has been appointed as the Chief Commercial Officer and is</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Aroa+Biosurgery+Limited+announces+the+recent+appointments+of+Michael+Lynskey+and+Mike+Falcon+to+its+US-based+commercial+team./26820941.html</guid>
   <pubDate>Tue, 28 Jul 2026 01:03:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.04540386</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.06505605</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ARX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00070321</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.09488366</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.14540318</category>
   	  </item>
  <item>
   <title>Aroa Biosurgery Limited announces the recent appointments of Michael Lynskey and Mike Falcon to its US-based commercial team.</title>
   <link>http://www.streetinsider.com/PRNewswire/Aroa+Biosurgery+Limited+announces+the+recent+appointments+of+Michael+Lynskey+and+Mike+Falcon+to+its+US-based+commercial+team./26820941.html</link>
   <description>
&lt;div class=&quot;xn-content&quot;&gt;
&lt;p&gt;&lt;span class=&quot;legendSpanClass&quot;&gt;&lt;location value=&quot;LU/nz..auckld&quot; idsrc=&quot;xmltag.org&quot; &gt;AUCKLAND, New Zealand&lt;/location&gt;&lt;/span&gt;, &lt;span class=&quot;legendSpanClass&quot;&gt;&lt;chron&gt;July 28, 2026&lt;/chron&gt;&lt;/span&gt; /PRNewswire/ -- &lt;span id=&quot;spanHghlt0915&quot;&gt;&lt;span value=&quot;Australia:ARX&quot; idsrc=&quot;xmltag.org&quot; &gt;Aroa Biosurgery Limited&lt;/span&gt; announces the recent appointments of &lt;person&gt;Michael Lynskey&lt;/person&gt; and &lt;person&gt;Mike Falcon&lt;/person&gt; to its US-based commercial team.&lt;/span&gt;&lt;/p&gt;
&lt;p&gt;AROA has been investing in expanding its commercial organisation to support its growth strategy and adoption of its AROA ECM™ technology. These appointments add seasoned leadership capability to support continued momentum across the Myriad product portfolio, and to capitalise on the recent market reset that has increased the opportunity for AROA's outpatient product, Symphony.&lt;/p&gt;&lt;p&gt;&lt;person&gt;Michael Lynskey&lt;/person&gt; has been appointed as the Chief Commercial Officer and is</description>
   <guid isPermaLink="true">http://www.streetinsider.com/PRNewswire/Aroa+Biosurgery+Limited+announces+the+recent+appointments+of+Michael+Lynskey+and+Mike+Falcon+to+its+US-based+commercial+team./26820941.html</guid>
   <pubDate>Tue, 28 Jul 2026 01:03:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.04540386</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.06505605</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ARX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00070321</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.09488366</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.14540318</category>
   	  </item>
  <item>
   <title>Aroa Biosurgery Limited announces the recent appointments of Michael Lynskey and Mike Falcon to its US-based commercial team.</title>
   <link>http://www.streetinsider.com/PRNewswire/Aroa+Biosurgery+Limited+announces+the+recent+appointments+of+Michael+Lynskey+and+Mike+Falcon+to+its+US-based+commercial+team./26820941.html</link>
   <description>
&lt;div class=&quot;xn-content&quot;&gt;
&lt;p&gt;&lt;span class=&quot;legendSpanClass&quot;&gt;&lt;location value=&quot;LU/nz..auckld&quot; idsrc=&quot;xmltag.org&quot; &gt;AUCKLAND, New Zealand&lt;/location&gt;&lt;/span&gt;, &lt;span class=&quot;legendSpanClass&quot;&gt;&lt;chron&gt;July 28, 2026&lt;/chron&gt;&lt;/span&gt; /PRNewswire/ -- &lt;span id=&quot;spanHghlt0915&quot;&gt;&lt;span value=&quot;Australia:ARX&quot; idsrc=&quot;xmltag.org&quot; &gt;Aroa Biosurgery Limited&lt;/span&gt; announces the recent appointments of &lt;person&gt;Michael Lynskey&lt;/person&gt; and &lt;person&gt;Mike Falcon&lt;/person&gt; to its US-based commercial team.&lt;/span&gt;&lt;/p&gt;
&lt;p&gt;AROA has been investing in expanding its commercial organisation to support its growth strategy and adoption of its AROA ECM™ technology. These appointments add seasoned leadership capability to support continued momentum across the Myriad product portfolio, and to capitalise on the recent market reset that has increased the opportunity for AROA's outpatient product, Symphony.&lt;/p&gt;&lt;p&gt;&lt;person&gt;Michael Lynskey&lt;/person&gt; has been appointed as the Chief Commercial Officer and is</description>
   <guid isPermaLink="true">http://www.streetinsider.com/PRNewswire/Aroa+Biosurgery+Limited+announces+the+recent+appointments+of+Michael+Lynskey+and+Mike+Falcon+to+its+US-based+commercial+team./26820941.html</guid>
   <pubDate>Tue, 28 Jul 2026 01:03:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.04540386</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.06505605</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ARX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00070321</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.09488366</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.14540318</category>
   	  </item>
  <item>
   <title>Aroa Biosurgery Limited announces the recent appointments of Michael Lynskey and Mike Falcon to its US-based commercial team.</title>
   <link>http://www.streetinsider.com/PRNewswire/Aroa+Biosurgery+Limited+announces+the+recent+appointments+of+Michael+Lynskey+and+Mike+Falcon+to+its+US-based+commercial+team./26820941.html</link>
   <description>
&lt;div class=&quot;xn-content&quot;&gt;
&lt;p&gt;&lt;span class=&quot;legendSpanClass&quot;&gt;&lt;location value=&quot;LU/nz..auckld&quot; idsrc=&quot;xmltag.org&quot; &gt;AUCKLAND, New Zealand&lt;/location&gt;&lt;/span&gt;, &lt;span class=&quot;legendSpanClass&quot;&gt;&lt;chron&gt;July 28, 2026&lt;/chron&gt;&lt;/span&gt; /PRNewswire/ -- &lt;span id=&quot;spanHghlt0915&quot;&gt;&lt;span value=&quot;Australia:ARX&quot; idsrc=&quot;xmltag.org&quot; &gt;Aroa Biosurgery Limited&lt;/span&gt; announces the recent appointments of &lt;person&gt;Michael Lynskey&lt;/person&gt; and &lt;person&gt;Mike Falcon&lt;/person&gt; to its US-based commercial team.&lt;/span&gt;&lt;/p&gt;
&lt;p&gt;AROA has been investing in expanding its commercial organisation to support its growth strategy and adoption of its AROA ECM™ technology. These appointments add seasoned leadership capability to support continued momentum across the Myriad product portfolio, and to capitalise on the recent market reset that has increased the opportunity for AROA's outpatient product, Symphony.&lt;/p&gt;&lt;p&gt;&lt;person&gt;Michael Lynskey&lt;/person&gt; has been appointed as the Chief Commercial Officer and is</description>
   <guid isPermaLink="true">http://www.streetinsider.com/PRNewswire/Aroa+Biosurgery+Limited+announces+the+recent+appointments+of+Michael+Lynskey+and+Mike+Falcon+to+its+US-based+commercial+team./26820941.html</guid>
   <pubDate>Tue, 28 Jul 2026 01:03:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.04540386</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.06505605</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ARX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00070321</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.09488366</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.14540318</category>
   	  </item>
  <item>
   <title>Aroa Biosurgery Limited announces the recent appointments of Michael Lynskey and Mike Falcon to its US-based commercial team.</title>
   <link>http://www.streetinsider.com/PRNewswire/Aroa+Biosurgery+Limited+announces+the+recent+appointments+of+Michael+Lynskey+and+Mike+Falcon+to+its+US-based+commercial+team./26820941.html</link>
   <description>
&lt;div class=&quot;xn-content&quot;&gt;
&lt;p&gt;&lt;span class=&quot;legendSpanClass&quot;&gt;&lt;location value=&quot;LU/nz..auckld&quot; idsrc=&quot;xmltag.org&quot; &gt;AUCKLAND, New Zealand&lt;/location&gt;&lt;/span&gt;, &lt;span class=&quot;legendSpanClass&quot;&gt;&lt;chron&gt;July 28, 2026&lt;/chron&gt;&lt;/span&gt; /PRNewswire/ -- &lt;span id=&quot;spanHghlt0915&quot;&gt;&lt;span value=&quot;Australia:ARX&quot; idsrc=&quot;xmltag.org&quot; &gt;Aroa Biosurgery Limited&lt;/span&gt; announces the recent appointments of &lt;person&gt;Michael Lynskey&lt;/person&gt; and &lt;person&gt;Mike Falcon&lt;/person&gt; to its US-based commercial team.&lt;/span&gt;&lt;/p&gt;
&lt;p&gt;AROA has been investing in expanding its commercial organisation to support its growth strategy and adoption of its AROA ECM™ technology. These appointments add seasoned leadership capability to support continued momentum across the Myriad product portfolio, and to capitalise on the recent market reset that has increased the opportunity for AROA's outpatient product, Symphony.&lt;/p&gt;&lt;p&gt;&lt;person&gt;Michael Lynskey&lt;/person&gt; has been appointed as the Chief Commercial Officer and is</description>
   <guid isPermaLink="true">http://www.streetinsider.com/PRNewswire/Aroa+Biosurgery+Limited+announces+the+recent+appointments+of+Michael+Lynskey+and+Mike+Falcon+to+its+US-based+commercial+team./26820941.html</guid>
   <pubDate>Tue, 28 Jul 2026 01:03:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.04540386</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.06505605</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ARX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00070321</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.09488366</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.14540318</category>
   	  </item>
  <item>
   <title>Aroa Biosurgery Limited announces the recent appointments of Michael Lynskey and Mike Falcon to its US-based commercial team.</title>
   <link>http://www.streetinsider.com/PRNewswire/Aroa+Biosurgery+Limited+announces+the+recent+appointments+of+Michael+Lynskey+and+Mike+Falcon+to+its+US-based+commercial+team./26820941.html</link>
   <description>
&lt;div class=&quot;xn-content&quot;&gt;
&lt;p&gt;&lt;span class=&quot;legendSpanClass&quot;&gt;&lt;location value=&quot;LU/nz..auckld&quot; idsrc=&quot;xmltag.org&quot; &gt;AUCKLAND, New Zealand&lt;/location&gt;&lt;/span&gt;, &lt;span class=&quot;legendSpanClass&quot;&gt;&lt;chron&gt;July 28, 2026&lt;/chron&gt;&lt;/span&gt; /PRNewswire/ -- &lt;span id=&quot;spanHghlt0915&quot;&gt;&lt;span value=&quot;Australia:ARX&quot; idsrc=&quot;xmltag.org&quot; &gt;Aroa Biosurgery Limited&lt;/span&gt; announces the recent appointments of &lt;person&gt;Michael Lynskey&lt;/person&gt; and &lt;person&gt;Mike Falcon&lt;/person&gt; to its US-based commercial team.&lt;/span&gt;&lt;/p&gt;
&lt;p&gt;AROA has been investing in expanding its commercial organisation to support its growth strategy and adoption of its AROA ECM™ technology. These appointments add seasoned leadership capability to support continued momentum across the Myriad product portfolio, and to capitalise on the recent market reset that has increased the opportunity for AROA's outpatient product, Symphony.&lt;/p&gt;&lt;p&gt;&lt;person&gt;Michael Lynskey&lt;/person&gt; has been appointed as the Chief Commercial Officer and is</description>
   <guid isPermaLink="true">http://www.streetinsider.com/PRNewswire/Aroa+Biosurgery+Limited+announces+the+recent+appointments+of+Michael+Lynskey+and+Mike+Falcon+to+its+US-based+commercial+team./26820941.html</guid>
   <pubDate>Tue, 28 Jul 2026 01:03:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.04540386</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.06505605</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ARX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00070321</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.09488366</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.14540318</category>
   	  </item>
  <item>
   <title>Aroa Biosurgery Limited announces the recent appointments of Michael Lynskey and Mike Falcon to its US-based commercial team.</title>
   <link>http://www.streetinsider.com/PRNewswire/Aroa+Biosurgery+Limited+announces+the+recent+appointments+of+Michael+Lynskey+and+Mike+Falcon+to+its+US-based+commercial+team./26820941.html</link>
   <description>
&lt;div class=&quot;xn-content&quot;&gt;
&lt;p&gt;&lt;span class=&quot;legendSpanClass&quot;&gt;&lt;location value=&quot;LU/nz..auckld&quot; idsrc=&quot;xmltag.org&quot; &gt;AUCKLAND, New Zealand&lt;/location&gt;&lt;/span&gt;, &lt;span class=&quot;legendSpanClass&quot;&gt;&lt;chron&gt;July 28, 2026&lt;/chron&gt;&lt;/span&gt; /PRNewswire/ -- &lt;span id=&quot;spanHghlt0915&quot;&gt;&lt;span value=&quot;Australia:ARX&quot; idsrc=&quot;xmltag.org&quot; &gt;Aroa Biosurgery Limited&lt;/span&gt; announces the recent appointments of &lt;person&gt;Michael Lynskey&lt;/person&gt; and &lt;person&gt;Mike Falcon&lt;/person&gt; to its US-based commercial team.&lt;/span&gt;&lt;/p&gt;
&lt;p&gt;AROA has been investing in expanding its commercial organisation to support its growth strategy and adoption of its AROA ECM™ technology. These appointments add seasoned leadership capability to support continued momentum across the Myriad product portfolio, and to capitalise on the recent market reset that has increased the opportunity for AROA's outpatient product, Symphony.&lt;/p&gt;&lt;p&gt;&lt;person&gt;Michael Lynskey&lt;/person&gt; has been appointed as the Chief Commercial Officer and is</description>
   <guid isPermaLink="true">http://www.streetinsider.com/PRNewswire/Aroa+Biosurgery+Limited+announces+the+recent+appointments+of+Michael+Lynskey+and+Mike+Falcon+to+its+US-based+commercial+team./26820941.html</guid>
   <pubDate>Tue, 28 Jul 2026 01:03:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.04540386</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.06505605</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ARX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00070321</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.09488366</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.14540318</category>
   	  </item>
  <item>
   <title>Form  4          Accelerant Holdings       For: Jul 23  Filed by: Sternberg Matthew David</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Accelerant+Holdings+++++++For%3A+Jul+23++Filed+by%3A+Sternberg+Matthew+David/26820872.html</link>
   <description>si-local-file:///var/storage/secattach/20260727/26820872.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Accelerant+Holdings+++++++For%3A+Jul+23++Filed+by%3A+Sternberg+Matthew+David/26820872.html</guid>
   <pubDate>Mon, 27 Jul 2026 21:38:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">ARX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.45217038</category>
   	  </item>
  <item>
   <title>Form  4          Accelerant Holdings       For: Jul 23  Filed by: Sternberg Matthew David</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Accelerant+Holdings+++++++For%3A+Jul+23++Filed+by%3A+Sternberg+Matthew+David/26820872.html</link>
   <description>si-local-file:///var/storage/secattach/20260727/26820872.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Accelerant+Holdings+++++++For%3A+Jul+23++Filed+by%3A+Sternberg+Matthew+David/26820872.html</guid>
   <pubDate>Mon, 27 Jul 2026 21:38:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">ARX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.45217038</category>
   	  </item>
  <item>
   <title>Form  144        Accelerant Holdings                    Filed by: Sternberg Matthew David</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++144++++++++Accelerant+Holdings++++++++++++++++++++Filed+by%3A+Sternberg+Matthew+David/26819848.html</link>
   <description>si-local-file:///var/storage/secattach/20260727/26819848.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++144++++++++Accelerant+Holdings++++++++++++++++++++Filed+by%3A+Sternberg+Matthew+David/26819848.html</guid>
   <pubDate>Mon, 27 Jul 2026 16:20:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">ARX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.45217038</category>
   	  </item>
  <item>
   <title>Form  144        Accelerant Holdings                    Filed by: Sternberg Matthew David</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++144++++++++Accelerant+Holdings++++++++++++++++++++Filed+by%3A+Sternberg+Matthew+David/26819848.html</link>
   <description>si-local-file:///var/storage/secattach/20260727/26819848.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++144++++++++Accelerant+Holdings++++++++++++++++++++Filed+by%3A+Sternberg+Matthew+David/26819848.html</guid>
   <pubDate>Mon, 27 Jul 2026 16:20:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">ARX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.45217038</category>
   	  </item>
  <item>
   <title>Form  144        Accelerant Holdings                    Filed by: RADKE JEFFREY L</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++144++++++++Accelerant+Holdings++++++++++++++++++++Filed+by%3A+RADKE+JEFFREY+L/26819820.html</link>
   <description>si-local-file:///var/storage/secattach/20260727/26819820.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++144++++++++Accelerant+Holdings++++++++++++++++++++Filed+by%3A+RADKE+JEFFREY+L/26819820.html</guid>
   <pubDate>Mon, 27 Jul 2026 16:18:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">ARX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.45217038</category>
   	  </item>
  <item>
   <title>Form  144        Accelerant Holdings                    Filed by: RADKE JEFFREY L</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++144++++++++Accelerant+Holdings++++++++++++++++++++Filed+by%3A+RADKE+JEFFREY+L/26819820.html</link>
   <description>si-local-file:///var/storage/secattach/20260727/26819820.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++144++++++++Accelerant+Holdings++++++++++++++++++++Filed+by%3A+RADKE+JEFFREY+L/26819820.html</guid>
   <pubDate>Mon, 27 Jul 2026 16:18:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">ARX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.45217038</category>
   	  </item>
  <item>
   <title>Form  144        Accelerant Holdings                    Filed by: RADKE JEFFREY L</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++144++++++++Accelerant+Holdings++++++++++++++++++++Filed+by%3A+RADKE+JEFFREY+L/26813014.html</link>
   <description>si-local-file:///var/storage/secattach/20260724/26813014.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++144++++++++Accelerant+Holdings++++++++++++++++++++Filed+by%3A+RADKE+JEFFREY+L/26813014.html</guid>
   <pubDate>Fri, 24 Jul 2026 14:16:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">ARX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.45217038</category>
   	  </item>
  <item>
   <title>Form  144        Accelerant Holdings                    Filed by: RADKE JEFFREY L</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++144++++++++Accelerant+Holdings++++++++++++++++++++Filed+by%3A+RADKE+JEFFREY+L/26813014.html</link>
   <description>si-local-file:///var/storage/secattach/20260724/26813014.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++144++++++++Accelerant+Holdings++++++++++++++++++++Filed+by%3A+RADKE+JEFFREY+L/26813014.html</guid>
   <pubDate>Fri, 24 Jul 2026 14:16:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">ARX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.45217038</category>
   	  </item>
  <item>
   <title>Accelerant Announces Date of Second Quarter 2026 Financial Results and Conference Call</title>
   <link>http://www.streetinsider.com/Press+Releases/Accelerant+Announces+Date+of+Second+Quarter+2026+Financial+Results+and+Conference+Call/26808222.html</link>
   <description>
&lt;p&gt;    ATLANTA--(BUSINESS WIRE)--
Accelerant Holdings (NYSE: ARX), the data-driven risk exchange platform transforming the specialty insurance marketplace through the Accelerant Risk Exchange, today announced that it will release financial results for the quarter ended June 30, 2026, before the market opens on Thursday, August 13, 2026. Accelerant will host a webcast and conference call the same day to discuss second quarter financial results at 8:00 A.M. Eastern Time.

&lt;/p&gt;&lt;p&gt;
&lt;b&gt;Webcast and Conference Call Details&lt;/b&gt;

&lt;/p&gt;&lt;ul class=&quot;bwlistdisc&quot;&gt;
&lt;li&gt;
&lt;b&gt;When:&lt;/b&gt; August 13, 2026 at 8:00 A.M. Eastern Time.

&lt;/li&gt;
&lt;li&gt;
&lt;b&gt;Webcast:&lt;/b&gt; A live webcast of the call can be accessed from the Investor Relations section of Accelerant’s website</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Accelerant+Announces+Date+of+Second+Quarter+2026+Financial+Results+and+Conference+Call/26808222.html</guid>
   <pubDate>Thu, 23 Jul 2026 16:15:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">ARX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.45217038</category>
   	  </item>
  <item>
   <title>Accelerant Announces Date of Second Quarter 2026 Financial Results and Conference Call</title>
   <link>http://www.streetinsider.com/Press+Releases/Accelerant+Announces+Date+of+Second+Quarter+2026+Financial+Results+and+Conference+Call/26808222.html</link>
   <description>
&lt;p&gt;    ATLANTA--(BUSINESS WIRE)--
Accelerant Holdings (NYSE: ARX), the data-driven risk exchange platform transforming the specialty insurance marketplace through the Accelerant Risk Exchange, today announced that it will release financial results for the quarter ended June 30, 2026, before the market opens on Thursday, August 13, 2026. Accelerant will host a webcast and conference call the same day to discuss second quarter financial results at 8:00 A.M. Eastern Time.

&lt;/p&gt;&lt;p&gt;
&lt;b&gt;Webcast and Conference Call Details&lt;/b&gt;

&lt;/p&gt;&lt;ul class=&quot;bwlistdisc&quot;&gt;
&lt;li&gt;
&lt;b&gt;When:&lt;/b&gt; August 13, 2026 at 8:00 A.M. Eastern Time.

&lt;/li&gt;
&lt;li&gt;
&lt;b&gt;Webcast:&lt;/b&gt; A live webcast of the call can be accessed from the Investor Relations section of Accelerant’s website</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Accelerant+Announces+Date+of+Second+Quarter+2026+Financial+Results+and+Conference+Call/26808222.html</guid>
   <pubDate>Thu, 23 Jul 2026 16:15:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">ARX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.45217038</category>
   	  </item>
  <item>
   <title>Accelerant Announces Date of Second Quarter 2026 Financial Results and Conference Call</title>
   <link>http://www.streetinsider.com/Business+Wire/Accelerant+Announces+Date+of+Second+Quarter+2026+Financial+Results+and+Conference+Call/26808222.html</link>
   <description>
&lt;p&gt;    ATLANTA--(BUSINESS WIRE)--
Accelerant Holdings (NYSE: ARX), the data-driven risk exchange platform transforming the specialty insurance marketplace through the Accelerant Risk Exchange, today announced that it will release financial results for the quarter ended June 30, 2026, before the market opens on Thursday, August 13, 2026. Accelerant will host a webcast and conference call the same day to discuss second quarter financial results at 8:00 A.M. Eastern Time.

&lt;/p&gt;&lt;p&gt;
&lt;b&gt;Webcast and Conference Call Details&lt;/b&gt;

&lt;/p&gt;&lt;ul class=&quot;bwlistdisc&quot;&gt;
&lt;li&gt;
&lt;b&gt;When:&lt;/b&gt; August 13, 2026 at 8:00 A.M. Eastern Time.

&lt;/li&gt;
&lt;li&gt;
&lt;b&gt;Webcast:&lt;/b&gt; A live webcast of the call can be accessed from the Investor Relations section of Accelerant’s website</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Business+Wire/Accelerant+Announces+Date+of+Second+Quarter+2026+Financial+Results+and+Conference+Call/26808222.html</guid>
   <pubDate>Thu, 23 Jul 2026 16:15:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">ARX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.45217038</category>
   	  </item>
  <item>
   <title>Accelerant Announces Date of Second Quarter 2026 Financial Results and Conference Call</title>
   <link>http://www.streetinsider.com/Business+Wire/Accelerant+Announces+Date+of+Second+Quarter+2026+Financial+Results+and+Conference+Call/26808222.html</link>
   <description>
&lt;p&gt;    ATLANTA--(BUSINESS WIRE)--
Accelerant Holdings (NYSE: ARX), the data-driven risk exchange platform transforming the specialty insurance marketplace through the Accelerant Risk Exchange, today announced that it will release financial results for the quarter ended June 30, 2026, before the market opens on Thursday, August 13, 2026. Accelerant will host a webcast and conference call the same day to discuss second quarter financial results at 8:00 A.M. Eastern Time.

&lt;/p&gt;&lt;p&gt;
&lt;b&gt;Webcast and Conference Call Details&lt;/b&gt;

&lt;/p&gt;&lt;ul class=&quot;bwlistdisc&quot;&gt;
&lt;li&gt;
&lt;b&gt;When:&lt;/b&gt; August 13, 2026 at 8:00 A.M. Eastern Time.

&lt;/li&gt;
&lt;li&gt;
&lt;b&gt;Webcast:&lt;/b&gt; A live webcast of the call can be accessed from the Investor Relations section of Accelerant’s website</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Business+Wire/Accelerant+Announces+Date+of+Second+Quarter+2026+Financial+Results+and+Conference+Call/26808222.html</guid>
   <pubDate>Thu, 23 Jul 2026 16:15:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">ARX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.45217038</category>
   	  </item>
  <item>
   <title>Form  4          Accelerant Holdings       For: Jul 17  Filed by: RADKE JEFFREY L</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Accelerant+Holdings+++++++For%3A+Jul+17++Filed+by%3A+RADKE+JEFFREY+L/26790783.html</link>
   <description>si-local-file:///var/storage/secattach/20260720/26790783.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Accelerant+Holdings+++++++For%3A+Jul+17++Filed+by%3A+RADKE+JEFFREY+L/26790783.html</guid>
   <pubDate>Mon, 20 Jul 2026 20:52:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">ARX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.45217038</category>
   	  </item>
 </channel>
</rss>
